Echo Therapeutics Announces $3 Million Financing
11/13/2009 10:53:25 AM
More...
|
Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients
11/4/2009 8:55:59 AM
More...
|
Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor Company Plans Clinical Trial Testing of Sensor in Near-Term
10/29/2009 8:35:55 AM
More...
|
Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference
10/1/2009 10:18:22 AM
More...
|
Echo Therapeutics to Present at Jessup & Lamont 2009 Growth Stock Conference
7/20/2009 9:13:08 AM
More...
|
Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference
7/9/2009 8:28:18 AM
More...
|
Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
6/17/2009 9:22:38 AM
More...
|
Echo Therapeutics Licenses Needle-Free Prelude SkinPrep System to Ferndale Pharma for Enhanced Delivery of Topical Lidocaine
5/29/2009 11:51:53 AM
More...
|
Echo Therapeutics Announces Issuance of New Patent for Symphony(TM) Transdermal Continuous Glucose Monitoring System
10/16/2008 11:23:20 AM
More...
|
Echo Therapeutics to Present at JMP Securities Healthcare Investor Conference
10/3/2008 3:45:44 PM
More...
|
|